Advisors, LLC, a leading provider of investment research and investor relations services in the life sciences sector, today announced that it has initiated coverage of ), a biotechnology company with a unique approach to treating debilitating neurodegenerative diseases.
http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22525
http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22525
No comments:
Post a Comment